Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **heme detoxification pathway in Plasmodium falciparum digestive vacuole** is an essential set of biochemical processes that allow the malaria parasite to survive inside red blood cells. As the parasite digests large amounts of host hemoglobin in a specialized acidic organelle called the digestive vacuole (DV), toxic free heme is released. Because free heme is highly reactive and can generate damaging radicals, the parasite rapidly converts it into **hemozoin**, an inert crystalline pigment, detoxifying heme and preventing cellular damage[1][3][5][8]. Key molecular players include a family of proteases (such as plasmepsins and falcipains) responsible for hemoglobin degradation, and specialized proteins such as **heme detoxification protein (HDP)** and **histidine-rich proteins (HRP II and HRP III)** that catalyze or promote the crystallization of heme into hemozoin[2][4][7]. The pathway represents a major target for frontline antimalarial drugs, such as chloroquine and artemisinin, which inhibit various stages of heme detoxification, leading to parasite death[1][9][10]. Drug resistance, notably via mutations in the chloroquine resistance transporter (CRT), poses a significant therapeutic challenge[10]. This pathway is specific to the biology of Plasmodium and is not found in humans, making it an attractive therapeutic target.
Inhibition of hemozoin (β-hematin/crystalline heme) formation, leading to toxic accumulation of free heme which is lethal to the parasite[1][2][3][9]; Complex formation with heme, preventing its detoxification; Direct binding to digestive vacuole components or proteins involved in the pathway
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heme detoxification pathway in Plasmodium falciparum digestive vacuole.